BiomX Inc (PHGE)
0.36
-0.01
(-2.33%)
USD |
NYAM |
May 09, 16:00
0.3601
0.00 (0.00%)
After-Hours: 20:00
BiomX Cash from Operations (Quarterly): -6.242M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.242M |
| September 30, 2023 | -5.922M |
| June 30, 2023 | -4.077M |
| March 31, 2023 | -5.045M |
| December 31, 2022 | -7.168M |
| September 30, 2022 | -5.476M |
| June 30, 2022 | -9.085M |
| March 31, 2022 | -7.363M |
| December 31, 2021 | -9.09M |
| September 30, 2021 | -5.684M |
| June 30, 2021 | -6.447M |
| Date | Value |
|---|---|
| March 31, 2021 | -6.352M |
| December 31, 2020 | -7.122M |
| September 30, 2020 | -5.918M |
| June 30, 2020 | -4.557M |
| March 31, 2020 | -6.85M |
| September 30, 2019 | -0.2699M |
| June 30, 2019 | -0.1025M |
| March 31, 2019 | -0.0261M |
| December 31, 2018 | -0.0753M |
| September 30, 2018 | -0.0006M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.09M
Minimum
Dec 2021
-0.1025M
Maximum
Jun 2019
-5.710M
Average
-6.082M
Median
Cash from Operations (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | 30.92M |
| InspireMD Inc | -4.177M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -3.649M |
| Holdco Nuvo Group DG Ltd | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.006M |
| Cash from Financing (Quarterly) | -1.324M |
| Free Cash Flow | -21.34M |
| Free Cash Flow Per Share (Quarterly) | -0.1029 |
| Free Cash Flow Yield | -115.6% |